Innovative platform for Rett syndrome research will facilitate future trials for treatments
The U.S. Department of Defense has awarded $13 million to Vanderbilt University Medical Center for a clinical trial of three drugs being repurposed to treat children with Rett syndrome. The drugs – ketamine, vorinostat and donepezil –…
Read more